Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Friday, May 8, 2026

Snapshot: May 8, 2026 · 6:00 PM 100 stocks analyzed

Up Day

Fri, May 8, 2026 Broad Rally High

Broad rally powered by tech earnings and AI deal flow, with extreme single-stock dispersion as mega-gainers like AEHL (+135%) and RKLB (+34%) offset scattered collapses on earni…

60% Broad rally across all three indices—S&P +0.82%, NASDAQ +1.71%, Russell 2000 +0.76%—with technology commanding 34% of the top 50 gainers, driven by major earnings beats (INOD +86% on $51M Big Tech contract, RKLB +34% on record $2.2B launch deal) and blockbuster AI infrastructure plays (Akamai +27% on $1.8B Anthropic deal, Rackspace +56% on AMD partnership).
25% Extreme dispersion across the tape with high single-stock volatility: top gainers averaged +33%, top losers averaged -27%, including dramatic first-time appearances (AEHL's +135% buyback/Bitcoin play, YMAT's +111% financing news) alongside a wave of earnings-driven collapses (Cloudflare -24% on 20% layoff, HubSpot -19% despite beat, DXC -21% on weak guidance).
15% Consumer cyclical and tech names bore most of the losses (26% and 22% of losers respectively), with merger blowups (BT Brands -35% on terminated deal) and margin misses (Amph -21%, Flux -21%, Heritage -20%) offsetting the tech sector's dominance, while VIX barely budged at +0.64%, signaling confidence beneath the surface churn.

Technology drove 34% of gainers 5 names returned after long absences AEHL — first appearance YMAT — first appearance

Market Regime

Fri, May 8, 2026 Risk-On conf: high macro · prototype

+41

Tailwind −100 … +100 · + tailwind / − headwind

VIX17.2 p48 Drawdown0.0% Held20d · extended SinceApr 13

Top drivers: S&P 20d return ▲ S&P vs 20d avg ▲ S&P vs 50d avg ▲

processId: history-market-regime

Market Indexes

Fri, May 8, 2026 4

S&P 500

7,397.43

+60.32

+0.82%

NASDAQ Composite

26,247.08

+440.88

+1.71%

Russell 2000

2,861.21

+21.58

+0.76%

VIX

17.19

+0.11

+0.64%

Biggest Gainers

Fri, May 8, 2026 50

AEHL

Antelope Enterprise Holdings LimitedIndustrials

$1.20+$0.69

+135.3%

NASDAQ · Mkt cap $6.5 M

Antelope Enterprise Holdings surged 135% after announcing a $95,000 share buyback program and reporting $190,000 in realized gains from its Bitcoin treasury strategy, signaling positive capital deployment and crypto holdings appreciation.

The headline establishes two concrete developments: a realized gain of $190,000 from Antelope's Bitcoin-focused "Genius Plan" capital allocation strategy and authorization of a $95,000 share repurchase program. For a micro-cap stock trading at $1.20, a six-figure gain from cryptocurrency holdings represents material financial progress, and the buyback announcement signals management confidence in undervaluation. The combination of demonstrated gains plus capital return to shareholders likely drove institutional and retail appetite. However, the headline is truncated and lacks detail on the company's overall financial health, whether these gains are recurring, or the timing and terms of the buyback, leaving some questions about sustainability of the move unanswered.

YMAT

J-Star Holding Co., Ltd. Ordinary SharesBasic Materials

$0.51+$0.27

+110.8%

NASDAQ · Mkt cap $7.3 M

J-Star Holding announced a memorandum of understanding with White Group to finance its Texas solid-state battery manufacturing facility, a positive development that likely triggered the 110% surge in the stock price on the same day as the announcement.

The headline establishes that J-Star signed an MOU with White Group focused on capital formation for an automated battery manufacturing project in Baytown, Texas. This is a material financing announcement for a company operating in the battery technology sector, which has attracted significant investor interest. The timing of the 110% gain on the same day as the news release suggests a direct causal link. Battery technology and manufacturing scale-up are capital-intensive endeavors, and securing financing commitments from a named partner represents concrete progress toward commercialization. For a micro-cap stock trading below one dollar, an MOU announcement of this nature can drive outsized percentage moves, particularly if the stock had been depressed or if investors view this as validation of the company's technology and business plan.

INOD

Innodata Inc.Technology

$84.89+$39.25

+86.0%

NASDAQ · Mkt cap $1.9 B

Innodata delivered record Q1 2026 results with a major $51 million Big Tech contract win and raised full-year guidance to 40%+ growth, triggering an 86% single-day surge as the market repriced the stock on dramatically improved fundamentals.

The headlines establish a clear, multi-faceted catalyst. Innodata reported record-setting Q1 revenue (up 54% year-over-year, beating consensus by 18%), crushed earnings estimates by 229%, and expanded adjusted gross margin to 47%. Management raised full-year 2026 revenue growth guidance from prior levels to approximately 40% or more. Critically, the company also announced a new $51 million contract with a leading Big Tech customer, which directly addresses AI data-service demand and validates the business model at scale. The combination of beat results, margin expansion, guidance raise, and a material new contract win created a near-perfect catalyst for institutional re-rating. The magnitude of the move reflects not just meeting expectations but substantially exceeding them across multiple dimensions simultaneously.

RKLX

Daily Target 2X Long RKLB ETF

$59.30+$23.94

+67.7%

NASDAQ

No news headlines were available in the last 48 hours, but RKLX is a 2X leveraged long ETF tracking Rocket Lab (RKLB), so a roughly 34% gain in the underlying stock would mechanically produce this ~67% move in the fund.

Yahoo Finance returned no headlines for the snapshot date or prior 48 hours, so no specific news catalyst can be identified from the provided sources. However, RKLX is a daily target 2X leveraged long ETF, meaning it is designed to deliver twice the daily return of its underlying asset, Rocket Lab (RKLB). A 67.7% gain in RKLX is consistent with approximately a 33-34% single-day gain in RKLB itself. Without access to RKLB-specific news, the cause could be a major positive announcement from Rocket Lab (contract award, mission success, guidance raise, partnership), a broad aerospace or space sector rally, or significant short covering in RKLB. The leverage structure alone accounts for the magnitude but does not explain why RKLB moved so sharply on this date.

RXT

Rackspace Technology, Inc.Technology

$5.49+$1.97

+56.0%

NASDAQ · Mkt cap $839 M

Rackspace surged 56% primarily on announcement of a multiyear strategic partnership with AMD to build governed enterprise AI infrastructure for regulated industries, coupled with return to profitability in Q1 2026 with $8.3 million net income.

The stock's explosive move was driven by two positive catalysts released on May 7. First, Rackspace reported Q1 2026 earnings showing a return to profitability after prior losses, with $678 million in revenue (up 2% year-over-year) and public cloud revenue growing 7%. More significantly, the company announced a Memorandum of Understanding with AMD for a multiyear collaboration to develop enterprise AI infrastructure tailored for regulated sectors. The headlines explicitly note that "the AMD partnership stole the show" despite a "so-so earnings report," indicating the partnership announcement was the dominant driver of the 55% jump. This positions Rackspace as a specialized player in the high-demand regulated AI infrastructure market, a narrative that resonated strongly with investors on the same trading day.

AIIO

Robo.ai Inc.Consumer Cyclical

$0.86+$0.27

+46.0%

NASDAQ · Mkt cap $487 M

Robo.ai announced a $100 million all-stock acquisition of Neurovia AI to expand its AI infrastructure capabilities, which likely drove the 46% single-day jump as investors saw validation of growth strategy and market position strengthening.

The acquisition announcement on May 8 provides clear structural support for the stock's sharp rise. Neurovia AI's focus on AI video processing, edge computing, and machine economy infrastructure aligns with a plausible growth narrative in high-demand AI infrastructure markets. The all-stock structure preserves cash and suggests management confidence in valuation, while the scale of the deal ($100 million) signals serious strategic intent in a hot sector. For a micro-cap stock trading near $0.86, acquisition news—especially one framed as capability-expanding rather than distressed—typically attracts retail and growth-focused investors. The timing and prominence of the announcement in financial feeds likely amplified intraday momentum. However, the lack of detail on earnings accretion, timeline, or integration risk means the full fundamentals remain unclear.

WEST

Westrock Coffee Company, LLCConsumer Defensive

$8.25+$2.35

+39.8%

NASDAQ · Mkt cap $750 M

Westrock Coffee surged 39.83% after reporting Q1 2026 earnings with revenue beating estimates by 5.44%, while achieving full operational integration of its beverage platform following construction completion.

Westrock Coffee released first-quarter 2026 results on May 7, highlighted by a revenue beat of 5.44% versus expectations. Although the company reported a net loss for the quarter, the earnings call emphasized a significant operational milestone: this was the first earnings report as a fully integrated beverage platform with all construction completed and all production lines operational. Management's statement that "the full enterprise now generating operat[ions]" suggests the company has transitioned from a build-out phase to a production phase, which investors likely interpret as a turning point toward profitability. The company also reaffirmed its 2026 outlook, signaling confidence despite the quarterly loss. The 39.83% single-day gain reflects investor relief and optimism around the completion of integration and the path to future profitability, combined with the revenue beat.

PTIX

Protagenic Therapeutics, Inc.Healthcare

$0.79+$0.21

+36.2%

NASDAQ · Mkt cap $652 K

No news headlines were found in the last 48 hours, so the +36% gain on PTIX cannot be attributed to a specific announced event; the move likely reflects either a delayed market reaction to earlier news, technical trading, or an untracked development.

The absence of any headlines in the Yahoo Finance RSS feed over the past 48 hours means we cannot connect this 36% intraday jump to a concrete catalyst such as clinical trial results, regulatory action, partnership announcement, or earnings. For a micro-cap biotech stock trading at $0.79, moves of this magnitude are not unusual and can be driven by several mechanisms. The most plausible categories include a delayed market reaction to news released more than 48 hours ago that has now gained traction among retail or institutional traders, a short squeeze if the stock has material short interest, technical breakout buying, or an untracked announcement that has not yet propagated to major news feeds. Without access to insider trading forms, message boards, or earnings calendars, it is difficult to narrow this further. The lack of headline coverage despite strong price action suggests either that the catalyst is recent and slow to reach aggregators, or that the move is being driven by trading dynamics rather than fundamental news.

RKLB

Rocket Lab USA, Inc.Industrials

$105.47+$26.89

+34.2%

NASDAQ · Mkt cap $41 B

Rocket Lab stock soared 34% following a strong Q1 2026 earnings beat, record $2.2 billion launch contract announcement, and revenue reaching $200 million in Q1 alone—more than the entire prior year.

The headlines establish a clear earnings-driven catalyst on May 7–8. Rocket Lab reported Q1 FY2026 results that exceeded expectations, with gross profit comparisons and revenue growth substantially outpacing prior-year figures. The company simultaneously announced its largest-ever launch services contract worth $2.2 billion, signaling major customer wins, likely in defense. Multiple headlines reference a record backlog of approximately $2 billion and progress on the Neutron rocket platform. The Q1 launch sales alone exceeded total 2025 full-year sales, indicating material acceleration in core business. This combination of earnings beat plus a transformational contract announcement is a high-conviction catalyst for aerospace and defense growth stocks. The move is consistent with a rerating of the company's profitability trajectory and competitive position against SpaceX alternatives.

VCX

Fundrise Growth Tech Fund, LLCFinancial Services

$190.99+$46.85

+32.5%

NYSE

No news was reported in the last 48 hours for VCX, so the 32.5% gain likely reflects a market event, technical rebound, or delayed disclosure not yet captured in headline feeds.

The absence of any news headlines in the last 48 hours makes direct attribution impossible. A 32.5% single-day jump for Fundrise Growth Tech Fund—a non-traded closed-end fund focused on private growth equity—typically would stem from either a significant net asset value update, a secondary market pricing adjustment after an illiquidity discount narrows, or broader sentiment shift in the private equity space. Non-traded funds like VCX sometimes experience sharp repricing when valuations of underlying holdings are refreshed or when secondary market demand shifts. Alternatively, the move could reflect technical trading, options-related activity, or a delayed announcement not yet reflected in the feeds searched. Without corroborating headlines, the specific catalyst remains unclear.

MULL

GraniteShares 2x Long MU Daily ETF

$475.95+$113.37

+31.3%

NASDAQ

No news headlines available in the last 48 hours, but MULL is a 2x leveraged ETF tracking Micron Technology, so a +31.27% surge most likely reflects a major rally in the underlying MU stock, which would be amplified roughly 2x by the fund's structure.

Zero relevant news headlines were found in the Yahoo Finance RSS feed for the past 48 hours, so there is no direct evidence of a specific catalyst such as an earnings beat, product announcement, or guidance raise. However, MULL is a daily 2x long leveraged ETF designed to track twice the daily performance of Micron Technology stock. A gain of roughly 15–16% in MU would mechanically produce a gain near 31% in MULL when accounting for compounding and fund fees. The most likely explanation is that Micron experienced a significant intraday rally—possibly driven by semiconductor sector momentum, positive commentary on memory chip demand, analyst upgrades, or contract wins—that was not yet captured in the headline feed at the time of this snapshot. Without access to the underlying MU price action or real-time market data, confirmation requires checking Micron's stock chart and any news specifically tied to that company.

CODX

Co-Diagnostics, Inc.Healthcare

$2.53+$0.60

+31.1%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics announced its joint venture CoMira finalized a manufacturing facility lease in Saudi Arabia's Sudair Industrial City on May 8, likely driving the 31% gain as a positive expansion milestone.

The headline from May 8 directly aligns with the timing of the +31% move. Co-Diagnostics announced that CoMira, its joint venture, completed a lease agreement for a manufacturing facility in Saudi Arabia. This represents operational progress and geographic expansion into the Middle East, which could signal revenue diversification and growth potential for the molecular diagnostics platform. The second headline about GoodRx (GDRX) appears unrelated to CODX's move. While the lease announcement is substantive, it does not disclose financial terms, production capacity timelines, or expected revenue impact, so investors are interpreting the strategic value of Middle Eastern manufacturing access rather than responding to quantified earnings or guidance changes.

MUU

Direxion Daily MU Bull 2X ETF

$542.72+$128.04

+30.9%

NASDAQ

No relevant news headlines available in the last 48 hours. MUU is a 2X leveraged bull ETF on Micron Technology, so a major move in Micron stock itself is the most probable cause of this gain.

The absence of news headlines in the provided data makes direct attribution impossible. However, MUU (Direxion Daily MU Bull 2X ETF) is a leveraged instrument that amplifies daily moves in Micron Technology (MU) stock by 2X. A 30.88% gain in MUU would imply approximately a 15% move in the underlying MU stock on May 8, 2026. This magnitude of move in a major semiconductor company would typically be driven by company-specific catalysts such as earnings results, forward guidance, large contract wins, competitive developments, or broader semiconductor sector strength. Without access to headlines from May 8 or intraday developments, the specific trigger cannot be confirmed from the provided data. The move could also reflect catch-up trading or volatility after a delayed market opening, though this is secondary to an underlying MU catalyst.

ARAY

Accuray IncorporatedHealthcare

$0.38+$0.09

+29.6%

NASDAQ · Mkt cap $35 M

Accuray's 29.65% gain on May 8 likely reflects a delayed market reaction to the May 6 Q3 earnings release, as the stock price snapshot was taken after the initial earnings announcement but the exact timing of investor response remains unclear from available data.

The most recent news shows Accuray released Q3 2026 earnings on May 6, 2026, with the company reporting modest sequential revenue growth but facing geopolitical disruptions and weakness in China, leading management to withdraw prior guidance. This is the only material corporate event evident in the provided headlines. The earnings release occurred two days before the May 8 price snapshot showing a 29.65% jump. While the headline language suggests a cautious or negative tone—withdrawal of guidance and headwinds are typically bearish signals—the magnitude of the gain is inconsistent with that narrative. This disconnect suggests either that the earnings results contained a specific positive element not captured in the headline summaries, or that the market reaction was driven by factors unrelated to the earnings announcement itself, such as short covering, sector rotation, or technical support levels.

AMN

AMN Healthcare Services, Inc.Healthcare

$28.97+$6.52

+29.0%

NYSE · Mkt cap $1.3 B

AMN Healthcare reported Q1 earnings that beat revenue and adjusted EPS estimates by significant margins, with 367% adjusted EPS growth driven by labor disruption demand and staffing gains, triggering the 29% rally.

AMN Healthcare released Q1 2026 results after market close on May 7, with revenue of $1.378 billion (up 99.9% year-over-year and beating estimates by 11.90%) and adjusted EPS of $2.10 (beating estimates by 30.98%, representing 367% growth). The earnings call and multiple news outlets highlighted that labor disruption and staffing gains drove the outperformance. The company was subsequently added to the Zacks Rank 1 Strong Buy list on May 8, and multiple analyst notes positioned it as a strong value play. One note mentions gross margin contraction, signaling a potential offset, but the top-line and bottom-line beats appear to have dominated investor sentiment. The synchronized publication of earnings results with analyst upgrades amplified the positive reception.

LINT

Direxion Daily INTC Bull 2X ETF

$230.74+$51.67

+28.9%

NASDAQ

No news headlines were found in the last 48 hours, but LINT is a 2X leveraged bull ETF on Intel, so a ~14.4% gain in the underlying INTC stock would mechanically produce this 28.85% move. Intel likely rallied on an untracked catalyst.

LINT (Direxion Daily INTC Bull 2X) is a daily-reset leveraged ETF designed to deliver twice the daily performance of Intel stock. With a 28.85% gain, the math implies the underlying Intel moved approximately 14.4% higher on this date. No news headlines appeared in the provided Yahoo Finance feed for the last 48 hours, so the specific catalyst is not identified in the sources available. However, for Intel to rise 14%+ in a single day typically requires a material positive catalyst such as earnings that beat expectations, major product announcement, activist involvement, strategic transaction rumors, or analyst upgrade. The absence of headlines does not mean no news occurred—it may indicate the move was driven by a non-news event such as short covering, technical breakout, or a delayed or emerging story not yet captured in the RSS feed.

WALD

Waldencast plcConsumer Defensive

$1.80+$0.40

+28.6%

NASDAQ · Mkt cap $171 M

WALD jumped 28.57% on a single mention in a penny stock highlight article published on May 8, but the article itself contains no company-specific news, earnings data, or catalyst—the move appears driven by inclusion in a bullish market roundup rather than fundamental developments.

The only headline provided is a generic market commentary piece titled "Spotlight On 3 Promising Penny Stocks With Market Caps Over $100M" published the morning of the move. The article discusses broad market strength (US market up 3.2% in seven days, up 31% over a year, with forecasted 16% annual earnings growth) but contains no specific information about WALD, no earnings announcement, no partnership, no clinical results, and no guidance change. The headline mentions WALD was included in the piece, but the substance of why it was highlighted is not provided in the excerpt. For a stock in this valuation range, a 28% single-day move on inclusion in a penny stock spotlight list suggests the catalyst was primarily attention and inclusion in a curated list rather than disclosure of new material facts. This is typical behavior for lower-liquidity equities that respond to sentiment and visibility shifts.

MASK

3 E Network Technology Group Ltd Class A Ordinary SharesTechnology

$3.18+$0.70

+28.2%

NASDAQ · Mkt cap $5.1 M

No news headlines were found in the last 48 hours to explain the 28.23% gain in MASK stock, so the driver remains unclear without additional reporting or company announcements.

Despite a strong single-day jump ranking MASK as the 18th biggest gainer on NASDAQ, no recent news headlines are available to identify a specific catalyst. This absence of reported news is notable given the magnitude of the move. For a relatively small-cap technology stock like 3E Network Technology Group, gains of this size can stem from several sources: a delayed earnings beat or guidance raise that may not yet have reached the RSS feed, an unannounced partnership or contract win, insider buying signals, or technical factors such as short covering or options-driven gamma effects. Low-volume stocks are also prone to intraday volatility from retail trading flows or rumors that don't always generate formal press coverage. Without headline evidence or knowledge of the company's specific business drivers, structural position, or short interest levels, any explanation remains speculative.

SIF

SIFCO Industries, Inc.Industrials

$19.86+$4.31

+27.7%

AMEX · Mkt cap $130 M

SIFCO Industries announced second quarter and first half fiscal 2026 financial results on May 8, driving a 27.72% single-day rally likely driven by better-than-expected earnings or improved guidance.

The timing of the announcement on May 8 at 12:12 UTC matches exactly with the date of the gain, establishing a clear temporal link between the earnings release and the 27.72% jump. The first headline explicitly states that SIFCO announced financial results for the period ended March 31, 2026, presented as second quarter and first half performance. While the headline itself does not specify whether results beat or missed expectations, the magnitude of the gain and its ranking as the 19th biggest mover of the day suggest investors reacted positively to disclosed metrics—likely revenue growth, profitability improvement, margin expansion, or forward guidance. The second headline about undiscovered gems in the US market is contextual noise and does not explain this specific stock's move. Without access to the actual financial figures or management commentary, we cannot pinpoint which specific metric drove the rally, but earnings announcements of this scale typically move small-cap industrials based on profitability surprises or strategic progress.

FLNC

Fluence Energy, Inc.Utilities

$24.16+$5.19

+27.4%

NASDAQ · Mkt cap $1.9 B

Fluence Energy surged 27% after reporting record backlog and major data center supply deals with AI hyperscalers, which overshadowed a revenue miss and net loss in Q2 2026 earnings released after hours on May 6.

The stock rally was driven by two contrasting elements in the Q2 2026 earnings report released May 6 after market close. On the negative side, Fluence missed revenue estimates by 28.5% and reported a net loss. However, the company posted a record backlog, accelerating order intake, and—most critically—secured major power supply contracts with two unnamed AI hyperscalers for data center applications. This forward-looking demand signal appears to have outweighed near-term earnings disappointment in investor sentiment. The stock extended gains through May 7-8, reaching +27% by May 8 snapshot date. Notably, analyst Roth Capital cut its price target on May 8, yet the stock continued climbing, suggesting institutional buying focused on the data center tailwind rather than current valuations. The hyperscaler deals validate Fluence's strategic pivot toward high-growth AI infrastructure demand.

VRAX

Virax Biolabs Group LimitedHealthcare

$0.17+$0.04

+26.7%

NASDAQ · Mkt cap $2.5 M

No news headlines were found in the last 48 hours for VRAX, so the 26.67% gain cannot be directly attributed to a disclosed catalyst. The move likely reflects technical trading, delayed news circulation, or retail speculation common to low-priced biotech stocks.

The absence of recent news headlines is the critical constraint here. VRAX is a very small-cap biotech stock trading at $0.17, a price point that often experiences volatile, retail-driven trading and is susceptible to technical momentum plays and rumor-based moves that may not be immediately captured in major news feeds. Possible explanations include a delayed or regional news announcement not yet syndicated to Yahoo Finance, short-covering in a thinly traded stock, or simple technical momentum as the stock bounces off support. Without access to SEC filings, press releases, or proprietary social media monitoring, we cannot pinpoint the driver. Biotech stocks at this valuation tier frequently gap on clinical trial updates, partnerships, or insider transactions that may circulate before formal news aggregation.

AKAM

Akamai Technologies, Inc.Technology

$147.71+$31.02

+26.6%

NASDAQ · Mkt cap $15 B

Akamai surged 26.58% after announcing a landmark $1.8 billion computing services deal with Anthropic to support AI software demand, combined with better-than-expected Q1 earnings and a broad tech sector rally.

The headlines establish a clear, material catalyst: Anthropic's $1.8 billion computing contract with Akamai announced on May 8th. Multiple sources confirm this is a major revenue driver for Akamai's cloud services business amid surging AI demand. The deal is explicitly cited as boosting revenue despite margin concerns, according to UBS analysis. Additionally, Akamai reported first-quarter earnings that beat consensus expectations, and the stock benefited from a synchronized upward move in the technology sector (Nasdaq up 1.7%, S&P 500 at new highs). The combination of a named enterprise contract worth nearly $2 billion, earnings results, and sector momentum provides a well-documented explanation for the 26.58% single-day gain, which was significant enough to rank the stock 22 among daily gainers.

PHOE

Phoenix Asia Holdings Limited Ordinary SharesIndustrials

$24.06+$5.00

+26.2%

NASDAQ · Mkt cap $526 M

No news headlines were found in the last 48 hours for PHOE, so the 26.23% gain cannot be attributed to a specific disclosed event. The move likely stems from technical trading, a delayed announcement, or market rumor.

Phoenix Asia Holdings Limited experienced a substantial single-day gain of over 26% with no corresponding news coverage in the Yahoo Finance RSS feed during the prior 48 hours. This disconnect between price action and public disclosure suggests either a timing lag between the market move and news propagation, a company announcement made through channels not captured in the RSS feed, or a catalyst unrelated to fundamental news such as short covering, options-related hedging dynamics, or technical momentum. Without access to the company's official press releases or exchange filings filed on May 8, 2026, or late May 7, it is impossible to definitively attribute the move to earnings, guidance, M&A, or strategic developments. The stock's relatively modest price point and NASDAQ listing suggest it may be subject to retail or momentum-driven trading patterns that can amplify moves on light volume.

DLLL

GraniteShares 2x Long DELL Daily ETF

$83.83+$17.31

+26.0%

NASDAQ

No news headlines were found in the last 48 hours, but DLLL is a 2x leveraged long ETF on Dell stock, so a +26% move likely reflects a sharp rally in Dell shares themselves, possibly driven by earnings, guidance, or sector momentum that has not yet appeared in the headline feed.

No news was available in the 48-hour window provided, so the direct cause cannot be confirmed from headlines. However, DLLL is a daily reset leveraged ETF with 2x long exposure to Dell Technologies. A +26% gain in a leveraged product of this kind typically amplifies an underlying move of roughly 13% in the stock itself. This magnitude of single-day move in Dell would usually be tied to a company-specific catalyst such as quarterly earnings results, forward guidance, a major deal, or significant sector news affecting large-cap technology or server hardware. The absence of headlines in the feed does not mean no news occurred; it may reflect a delay in syndication, or the catalyst may have dropped after the RSS window closed. Alternatively, a sharp technical or momentum-driven rally in Dell could also drive this move without new fundamental news.

EOSE

Eos Energy Enterprises, Inc.Industrials

$8.01+$1.65

+25.9%

NASDAQ · Mkt cap $1.3 B

No news about EOSE was provided; the 25.94% jump likely reflects a broader market catalyst, technical rebound, or sector-specific driver affecting energy storage stocks that day.

The only headline in the dataset concerns LegalZoom earnings, which is completely unrelated to Eos Energy Enterprises, a battery storage technology company. No EOSE-specific news is present to explain the move. Eos Energy operates in the long-duration energy storage sector, which can be sensitive to regulatory announcements (grid storage incentives, IRA funding), commodity prices (zinc, bromine), contract wins, or quarterly guidance. A 26% single-day move in a micro-cap energy stock is also consistent with short covering, technical oversold conditions, or a delayed announcement that hasn't yet surfaced in the RSS feed. Without EOSE-related headlines, the cause cannot be pinned to a specific event.

ANPA

Rich Sparkle Holdings Limited Ordinary SharesIndustrials

$7.18+$1.46

+25.5%

NASDAQ · Mkt cap $64 M

No news headlines were available in the last 48 hours to explain ANPA's 25.52% jump, so the cause remains unclear without additional information about company announcements or market events.

Rich Sparkle Holdings Limited showed a strong single-day gain of approximately 25.52%, ranking it among the top gainers on NASDAQ. However, no recent news headlines from Yahoo Finance are available to ground the move in a specific catalyst such as earnings, guidance, corporate actions, or regulatory developments. Without confirmed information, several generic explanations are possible for a microcap or thinly traded name like this: delayed disclosure of company news not yet indexed by major news aggregators, short covering or technical momentum buying, retail interest or social media attention, or potentially an unconfirmed rumor in less mainstream channels. The absence of news does not rule out a legitimate corporate event; it simply means we cannot identify it from the sources provided.

MRAM

Everspin Technologies, Inc.Technology

$26.99+$5.48

+25.5%

NASDAQ · Mkt cap $425 M

Everspin announced a $40M military-aerospace MRAM contract on April 30 and an analyst upgraded fair value to $18 on May 7, both catalysts firing within 48 hours and likely driving the 25% rally.

The headline evidence points to two specific near-term catalysts. First, Everspin announced execution of a $40 million agreement for military and aerospace MRAM applications, a material contract win for a semiconductor specialist. Second, on May 7 an analyst raised fair value from $12.50 to $18.00 per share, moving notably above the Street consensus of $14.00, signaling meaningful upward revision in expected cash generation or growth trajectory. The timing of the contract announcement (April 30) combined with the valuation reset (May 7) likely triggered institutional and retail buying into a stock that appears to have been undervalued relative to new visibility. The contract suggests MRAM demand is accelerating in high-value defense applications, which supports the analyst's higher fair value estimate.

ZTEK

Zentek Ltd.Healthcare

$0.75+$0.15

+25.1%

NASDAQ · Mkt cap $75 M

No news headlines were found in the last 48 hours, so the 25% gain likely stems from technical trading activity, a delayed press release not yet indexed, or market speculation in a low-priced microcap stock.

Zentek Ltd. is trading at $0.75 and ranks among the top 28 gainers of the day with a 25% intraday move, yet no headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect is not uncommon in microcap and penny-stock trading, where price swings can be driven by technical catalysts (short covering, option expiration, support levels), news that has not yet propagated through major feeds, or retail investor attention on social platforms. Without a named catalyst—earnings beat, clinical trial result, partnership, or guidance revision—we cannot pinpoint a specific event. The absence of news does not rule out a legitimate company announcement; it may simply indicate a lag in indexing or that the move preceded media pickup.

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$10.01+$2.01

+25.1%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours, so the 25% gain on STFS likely reflects either a delayed announcement not yet picked up by Yahoo Finance, technical/short-covering activity, or a rumor-driven rally in a lower-liquidity name.

Star Fashion Culture Holdings is a small-cap apparel company on NASDAQ, and the absence of any news in the last 48 hours makes it difficult to pinpoint a specific catalyst. A 25% single-day move in a stock of this size and profile often occurs when there is material information not yet widely disseminated, short covering in a name with limited float, or sentiment shifts driven by social media or retail trader activity rather than fundamental news. Fashion and consumer discretionary stocks can also be sensitive to sector rotations or broad market shifts in growth sentiment. Without confirmed headlines, the most honest assessment is that the underlying cause remains unclear from publicly available sources captured here.

MNTS

Momentus Inc.Industrials

$5.46+$1.05

+23.8%

NASDAQ · Mkt cap $80 M

No news headlines were found in the last 48 hours, so the 23.81% gain cannot be directly attributed to a disclosed catalyst. The move likely reflects either delayed market reaction to prior developments, technical trading, or undisclosed developments.

Momentus Inc. is a space infrastructure and orbital transfer vehicle company, the type of equity that can experience sharp intraday moves on thin volume or sentiment shifts even without fresh public news. The absence of news in the last 48 hours means the headline-driven explanation is ruled out. Possible drivers include catch-up pricing on prior company announcements, options-related hedging expiration, short covering, or retail momentum trading. Without access to intraday volume, social media sentiment, or insider filings, we cannot confirm which of these mechanisms drove the move. Space stocks can also be sensitive to broader industry sentiment or geopolitical developments affecting government contracting, which may not always appear in real-time financial news feeds.

PGNY

Progyny, Inc.Healthcare

$23.72+$4.56

+23.8%

NASDAQ · Mkt cap $2.0 B

Progyny beat Wall Street estimates on Q1 2026 earnings and revenue while reporting record quarterly revenue of $328.5 million and maintaining aggressive share buybacks, driving a 23.8% gain in the stock.

Progyny reported first-quarter results on May 7 that substantially exceeded investor expectations. The company delivered earnings that beat estimates by 14.50% and revenue that beat by 0.29%, with absolute revenue reaching a record $328.5 million, up 1.4% year-on-year. Management characterized it as a strong start to 2026 with profitability exceeding expectations despite continued platform investments. The fertility benefits company also expanded its client base and repurchased 8.8 million shares, demonstrating confidence in its business trajectory. Early selling season activity cited in the earnings commentary reflects robust demand for women's health and family building solutions. Although prior guidance had suggested flat year-over-year revenue, the actual results and forward guidance appear to have impressed the market sufficiently to warrant this significant single-day appreciation.

FROG

JFrog Ltd.Technology

$70.55+$13.53

+23.7%

MRVI

Maravai LifeSciences Holdings, Inc.Healthcare

$4.85+$0.91

+23.1%

NASDAQ · Mkt cap $2.7 B

Maravai LifeSciences delivered a substantial Q1 earnings beat (EPS +121% and revenue +20.66%) with management citing strong TriLink segment growth and Cygnus contributions, driving the +23% rally.

The stock's 23% jump on May 8 aligns precisely with the earnings release and conference call highlights from the prior evening. The company reported earnings per share that exceeded estimates by 121 percent while revenue beat expectations by 20.66 percent, both material surprises that typically warrant significant upside repricing. Management's characterization of Q1 as a "strong start to 2026" and the positive contribution from two named business segments (TriLink and Cygnus) reinforce an upside narrative. The headlines establish that this is a fundamental earnings-driven move rather than speculation or technical action. No guidance changes, M&A activity, or regulatory catalysts are mentioned in the available coverage, so the move appears attributable to reported results beating analyst consensus on both top and bottom lines.

AMUU

Direxion Daily AMD Bull 2X ETF

$194.93+$36.57

+23.1%

NASDAQ

No news headlines were published in the last 48 hours, but AMUU surged 23.09% likely due to a sharp rally in its underlying security, AMD, since this is a 2X leveraged bull ETF that amplifies daily moves in that stock.

AMUU is a leveraged ETF designed to deliver twice the daily return of AMD stock. With no headlines provided for the last 48 hours, the price action cannot be directly tied to company-specific news. However, the mechanism of this security explains the move: if AMD rose roughly 11-12% on May 8, AMUU would be expected to rise approximately 22-24% as a mathematical consequence of its 2X leverage structure. The catalyst for AMD's underlying move is not established by the data provided, but common drivers for semiconductor stocks include broad market gains, positive industry sentiment, analyst upgrades, short covering, or delayed reaction to earlier announcements. Without headline evidence, the cause remains unknown at the company level.

AMDL

GraniteShares 2x Long AMD Daily ETF

$55.74+$10.35

+22.8%

NASDAQ

No news headlines were found in the last 48 hours, but AMDL is a 2x leveraged long ETF tracking AMD, so a large move in AMD stock would mechanically amplify to roughly double the gain in this fund, making a 22.80% jump plausible if AMD gained approximately 11% on positive catalyst unmentioned in …

The absence of recent news headlines makes direct attribution impossible from the information provided. However, AMDL's structure as a 2x long daily leveraged ETF on AMD means it is designed to deliver twice the daily return of its underlying asset. A roughly 11% move in AMD stock would translate to approximately a 22% move in AMDL, which matches the observed +22.80% gain. The most likely causes fall into two categories: first, AMD itself experienced a significant positive catalyst such as positive earnings guidance, a major product announcement, or favorable industry news that was not captured in the Yahoo Finance headlines provided; second, market sentiment shifted sharply in favor of semiconductor stocks or AI-related equities more broadly. Without the actual AMD price action or semiconductor sector news for the relevant period, we cannot distinguish between these scenarios or rule out other possibilities entirely.

FLY

Firefly Aerospace Inc.Industrials

$39.68+$7.32

+22.6%

NASDAQ · Mkt cap $3.5 B

Firefly Aerospace jumped 22.6% likely due to investor enthusiasm around the space industry's growth prospects, with the article positioning Firefly as an accessible alternative to SpaceX ahead of potential major IPO activity and sector tailwinds in 2026.

The provided headline from May 7 frames Firefly as "the space stock you can actually buy today" in contrast to SpaceX's anticipated IPO, suggesting comparative valuation appeal and positioning Firefly to capture investor interest in commercial spaceflight. While the article excerpt does not announce a specific contract, earnings beat, or company-specific catalyst, it does establish favorable narrative momentum around the space sector broadly and Firefly's role within it. The timing suggests the article may have reached a wider audience on May 8, triggering buying interest. However, the headline alone does not confirm a discrete corporate event (funding round, launch success, customer contract) that directly triggered the move. The jump is plausibly driven by sector rotation into space stocks and improved sentiment toward Firefly's market position relative to private competitors.

KORU

Direxion Daily MSCI South Korea Bull 3X ETF

$942.18+$173.73

+22.6%

AMEX

No news headlines were found in the last 48 hours, but KORU is a 3X leveraged ETF tracking South Korean equities, so a +22.61% move likely reflects a sharp rally in the underlying MSCI South Korea index amplified by its triple leverage.

The absence of KORU-specific news in the provided headlines makes direct attribution difficult. However, KORU is a daily-reset leveraged inverse-or-bullish ETF product, meaning its price movement is mechanically derived from the MSCI South Korea Index multiplied by three. A gain of approximately 7.5% in the underlying index would produce the observed +22.61% move when leverage is applied. Possible catalysts for a Korean market rally on this date could include positive macroeconomic data from South Korea, a broader risk-on sentiment shift benefiting emerging markets, central bank or government policy announcements, or significant corporate earnings beats from South Korea's largest companies. Without specific news linking to KORU or the Korean market, structural leverage remains the clearest partial explanation of the magnitude of the move, though the underlying trigger remains unknown.

MRDN

Meridian Holdings Inc.Consumer Cyclical

$13.44+$2.46

+22.4%

NASDAQ · Mkt cap $169 M

No news directly explaining the 22.4% jump has been reported yet. The only recent headline is an announcement of a fireside chat scheduled for May 12, which is four days after this price move and unlikely to be its cause.

The provided headline announces an upcoming investor event on May 12 featuring Meridian Holdings' interim leadership, but this is scheduled for after the price jump occurred on May 8. The fireside chat itself would not typically drive a 22% gain in advance, as such events are routine disclosure forums. Without explanatory news in the past 48 hours, the move falls into technical or speculative territory. Possible causes include: short covering or a squeeze in a thinly traded position, market rotation favoring the sector, or an unpublished rumor circulating among retail or institutional traders. The interim CEO designation suggests recent leadership transition, which could spark renewed interest if investor confidence has shifted. However, this remains inference without concrete evidence.

BKSY

BlackSky Technology Inc.Industrials

$39.45+$7.21

+22.4%

NYSE · Mkt cap $844 M

BlackSky reported Q1 2026 earnings on May 7-8, triggering a 22% gain despite missing revenue estimates and posting a net loss, likely driven by improved forward guidance, commercialization progress on Gen-3 satellites, or positive analyst sentiment on the space sector tailwind.

BlackSky released Q1 2026 results on May 7, with the earnings call occurring on May 8 when the stock jumped 22%. The headlines reveal mixed headline numbers: the company lagged revenue estimates by 26.66% and posted an EPS surprise of negative 120.13%, indicating a loss. However, multiple subsequent headlines reference analyst coverage updates and discussions of key metrics, suggesting the market may have focused on forward-looking commentary rather than backward-looking earnings misses. One headline specifically mentions "clearer Gen-3 commercial" progress, indicating satellite commercialization momentum. Additionally, the broader space sector rallied on May 8, with Rocket Lab jumping over 25%, suggesting a sector-wide tailwind. The gain likely reflects management guidance, commercial traction on next-generation satellites, or improved investor sentiment on space stocks generally, rather than the earnings beat itself.

MRNX

Daily Target 2X Long MRNA ETF

$28.40+$5.19

+22.4%

AMEX

No news headlines were found in the last 48 hours, but MRNX is a 2X leveraged long ETF on Moderna, so a 22.36% jump likely reflects a significant gain in the underlying MRNA stock amplified by the fund's leverage mechanics.

Zero news headlines appear in the provided 48-hour window, so there is no direct evidence of a specific catalyst such as an earnings beat, FDA approval, partnership, or guidance change. However, MRNX is structurally a daily-reset leveraged ETF designed to deliver twice the daily return of Moderna stock. A 22.36% move in MRNX implies roughly an 11% gain in MRNA itself, which is substantial enough to warrant investigation into Moderna-specific developments that may not yet be reflected in Yahoo's RSS feed, or a delayed market reaction to earlier news. Alternatively, the move could reflect technical momentum, short covering, or broader sector strength in biotech. Without access to the underlying MRNA price action or contemporaneous announcements, the exact trigger remains unknown.

CELG-RI

Bristol-Myers Squibb Company Ce

$0.13+$0.02

+22.3%

TRGSR

TRG Latin America Acquisitions Corp. Rights

$0.22+$0.04

+22.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 22% gain in TRGSR rights is likely driven by technical factors, speculative positioning, or delayed reporting of a corporate event.

TRGSR is a rights offering associated with a SPAC (TRG Latin America Acquisitions Corp.), a security type that can exhibit outsized volatility on small volume and often trades on sentiment around the underlying acquisition target or overall SPAC sector momentum. The absence of news in the Yahoo Finance RSS feed over the past 48 hours does not rule out an actual corporate development—such announcements may have been made outside standard news feeds, or the market may be reacting to a prior announcement with delayed pricing. Rights offerings are also sensitive to changes in the stock price of the sponsor entity and redemption dynamics. Without specific evidence of a catalyst, the move likely reflects technical trading, short covering, or renewed retail interest in the SPAC space, rather than a fundamental development we can identify from available sources.

CHARR

Charlton Aria Acquisition Corporation

$0.09+$0.02

+22.1%

NASDAQ

No news headlines were found in the last 48 hours, so the 22% gain on this low-priced SPAC stock is likely driven by technical momentum, retail speculation, or a delayed announcement not yet captured in the RSS feed.

Charlton Aria Acquisition Corporation is a blank-check company (SPAC), and no recent news was available to explain today's jump. Low-priced SPACs are typically sensitive to small-volume trades and retail speculation, and a 22% move on a nine-cent stock can result from relatively modest absolute dollar volume. The spike could reflect technical momentum, short-covering, or awareness of an upcoming merger announcement or deadline that has not yet appeared in major financial RSS feeds. SPACs often experience sudden moves tied to shareholder votes, extension deadlines, or unconfirmed merger rumors. Without corroborating headlines, any specific explanation remains speculative.

REPL

Replimune Group, Inc.Healthcare

$4.07+$0.73

+21.9%

TEAD

Teads Holding Co.Communication Services

$1.06+$0.19

+21.6%

NASDAQ · Mkt cap $61 M

Teads announced first quarter 2026 financial results on May 7, likely containing positive or better-than-expected metrics that drove the 21.64% rally on May 8.

The RSS headline indicates Teads released Q1 2026 results on May 7, 2026, with the announcement noting "First Quarter 2026 Key Financial Metrics" but the actual figures and details are truncated in the provided snippet. The timing of the announcement one day before the observed price jump on May 8 strongly suggests the earnings release triggered the move. However, the specific metrics—revenue, profitability, user growth, or guidance revisions—are not visible in the headline excerpt provided. The 21.64% gain is substantial and ranks the stock among the day's top 45 gainers, which is consistent with positive earnings surprise or upside guidance. Without seeing the actual financial numbers or any commentary on performance drivers, we cannot pinpoint which specific metric or forward guidance element caused the market enthusiasm.

AMDG

Leverage Shares 2x Long AMD Daily ETF

$94.29+$16.68

+21.5%

NASDAQ

No news headlines were found in the last 48 hours. AMDG's 21.49% gain most likely reflects a sharp rise in the underlying AMD stock price, which the 2x leveraged ETF would amplify approximately twofold on an intraday basis.

AMDG is a 2x daily leveraged long ETF tracking AMD, meaning its price moves are designed to be roughly double those of AMD on a given trading day. With no news identified for AMDG itself in the past 48 hours, the driver is almost certainly AMD's own price action. For AMDG to gain 21.49%, AMD would need to rise roughly 10-11% on this single day. Without headlines provided for AMD, the cause of that underlying move remains unknown but could span earnings surprises, analyst upgrades, sector momentum, a major contract or partnership, guidance beats, or broad market rotation into semiconductor stocks. The absence of news does not mean no catalyst occurred; news may simply not yet be indexed by Yahoo Finance RSS at the time of this snapshot, or the move may be driven by intraday technical factors or options activity.

DXYZ

Destiny Tech100 Inc.Financial Services

$54.61+$9.61

+21.4%

NYSE · Mkt cap $983 M

The provided headline about a potential SpaceX IPO is tangentially related to Destiny Tech100 but does not directly explain a 21.36% jump. The surge likely reflects either investor speculation that DXYZ will gain SpaceX IPO exposure or an unrelated catalyst not captured in the news feed.

The single headline discusses SpaceX IPO investment opportunities but does not mention DXYZ directly or announce any specific partnership, allocation, or fund restructuring. Destiny Tech100 is a venture capital-focused ETF that tracks early-stage and pre-IPO companies, so a SpaceX IPO announcement could theoretically make it a relevant holding or acquisition target. However, this represents inference rather than established fact from the headlines. The magnitude of the gain suggests either a significant portfolio announcement tied to SpaceX access, or an entirely separate catalyst not reflected in the provided news. Without confirmation that DXYZ secured SpaceX IPO allocation or announced a related strategic move, the connection remains speculative.

PYXS

Pyxis Oncology, Inc.Healthcare

$2.74+$0.48

+21.2%

NASDAQ · Mkt cap $214 M

Pyxis Oncology announced the appointment of Nelson Azoulay as Chief Business Officer on May 7, likely signaling organizational strengthening ahead of clinical or commercial milestones, driving a 21% single-day gain.

The only substantive news in the past 48 hours is the executive appointment announcement on May 7, which preceded the May 8 price jump. For a clinical-stage oncology company, C-suite additions often signal investor confidence in near-term catalysts such as clinical trial progress, potential partnerships, or fundraising readiness. The appointment of a Chief Business Officer specifically suggests preparation for business development or commercial activities. However, the headline provided does not contain details about Azoulay's background, the company's pipeline status, or any new clinical data or partnerships. The move alone—an executive hire—is typically a modest positive but can drive outsized enthusiasm in small-cap biotech if paired with market anticipation of trial results or partnership news not yet disclosed in the RSS feed. Without additional context on the company's clinical progress or financial condition, the appointment serves as a proximate catalyst but likely reflects underlying positive momentum rather than fully explaining the magnitude of the gain.

MXL

MaxLinear, Inc.Technology

$99.83+$17.46

+21.2%

MGRX

Mangoceuticals, Inc.Healthcare

$0.41+$0.07

+20.8%

NASDAQ · Mkt cap $7.2 M

No news headlines were found in the last 48 hours, so the 20.85% gain cannot be attributed to a specific disclosed event. The move likely reflects technical trading, delayed news digestion, or undisclosed catalysts.

The absence of any Yahoo Finance headlines in the 48-hour window preceding this gain means we cannot identify a specific corporate action, earnings surprise, FDA decision, or strategic announcement as the direct cause. For a micro-cap stock like MGRX trading at $0.41, price moves of this magnitude are not uncommon and often reflect low liquidity, retail interest, or technical breakouts rather than fundamental catalysts. Possible explanations include a delayed market reaction to news released outside the RSS feed window, short covering, options-related gamma activity, or discussion on social media platforms that precedes formal news distribution. Without a confirmed headline-driven event, any specific attribution would be speculation.

Biggest Losers

Fri, May 8, 2026 50

POM

POMDOCTOR LtdHealthcare

$0.08−$0.46

-85.9%

NASDAQ · Mkt cap $7.0 M

POM collapsed 85.88% with no news reported in the last 48 hours, suggesting a delayed announcement, technical breakdown, or liquidity crisis rather than a transparent market event.

The absence of any recent headlines in a stock experiencing the single largest one-day loss on its exchange is striking and limits causal analysis. For a sub-dime penny stock like POMDOCTOR Ltd, the most likely explanations fall into a few categories. First, a material announcement (bankruptcy filing, regulatory suspension, failed clinical trial, or delisting notice) may have been released outside the Yahoo Finance RSS feed window or posted directly to SEC filings or company channels before appearing in news aggregators. Second, a technical or structural event such as a reverse split, rights offering expiration, warrant expiration, or brokerage mass liquidation could trigger sharp declines in illiquid micro-cap stocks without generating press coverage. Third, coordinated short-selling or rumor-driven panic on bulletin boards could cause a crash in a thinly traded stock with minimal float. Without access to SEC filings, company announcements, or broader financial news sources beyond the 48-hour RSS window, confirmation is not possible.

RKLZ

DEFIANCE DAILY TARGET 2X SHORT RKLB ETF

$4.05−$8.79

-68.5%

NASDAQ

No news headlines were found in the last 48 hours, but RKLZ is a 2x inverse leveraged ETF on Rocket Lab (RKLB), so a steep loss likely reflects a sharp gain in RKLB stock that the short position amplified.

RKLZ is a daily reset inverse leveraged ETF designed to move negative 2x relative to Rocket Lab's stock price. With no news about RKLZ or RKLB appearing in the last 48 hours, the 68% decline in this ETF most likely reflects a significant rally in the underlying RKLB stock, which would be amplified roughly twofold in the inverse direction. This type of leveraged ETF is extremely sensitive to daily moves in its underlying and also experiences decay over time due to compounding effects. Without specific news about RKLB, the catalyst could be positive developments for Rocket Lab itself such as a contract announcement, quarterly results, industry tailwinds, or technical momentum. The absence of any headline does not rule out that RKLB moved sharply; it only means such news was not captured in this particular feed.

RPGL

Republic Power Group Limited Class A Ordinary SharesTechnology

$0.83−$1.47

-63.7%

NASDAQ · Mkt cap $2.6 M

No news headlines were found in the last 48 hours, so the 63.7% collapse in RPGL shares likely stems from a company-specific event, broader market downturn, or undisclosed catalyst not yet reflected in available news feeds.

Republic Power Group Limited experienced one of the largest single-day losses on the market with a 63.7% decline, yet no headlines explaining the move appeared in the last 48 hours. This disconnect between magnitude of move and news coverage suggests either a very recent development not yet widely reported, a delayed news index update, or an undisclosed catalyst affecting the stock. For a micro-cap equity trading near $0.83, common causes of such severe declines include: adverse regulatory or legal developments, insider selling or lock-up expiration, sharp earnings misses, credit or solvency concerns, reverse split announcements, or fundamental business deterioration. Without concrete news, determining the specific driver is not possible from available evidence.

NETG

Leverage Shares 2x Long NET Daily ETF

$9.25−$8.27

-47.2%

NASDAQ

No news headlines were found in the last 48 hours, but NETG is a 2x leveraged long ETF on Cloudflare (NET), so a roughly 23-24% drop in NET would mechanically produce this loss through daily rebalancing and leverage decay.

The absence of news in the Yahoo Finance RSS feed means we cannot point to a company-specific catalyst for Cloudflare or a market-wide shock. However, NETG is a daily reset 2x leveraged product that amplifies moves in the underlying NET stock. A 47% drop in a leveraged ETF typically reflects either a sharp single-day decline in the underlying asset, cumulative leverage decay from volatility, or both. If NET fell roughly 23-24% on May 8, the mechanical amplification would explain most of this loss. If the underlying move was smaller, leverage decay from recent volatility would account for the remainder. Without access to NET's price action on this date or Cloudflare news, we cannot confirm the root cause, but the magnitude is consistent with underlying stock weakness amplified by the ETF structure.

FWRD

Forward Air CorporationIndustrials

$9.87−$7.46

-43.0%

NASDAQ · Mkt cap $551 M

Forward Air reported a Q1 loss and missed revenue estimates by 6.12%, and disclosed a potential transition of business from a major customer, triggering the 43% sell-off.

Forward Air released first-quarter 2026 results after market close on May 7, 2026, delivering a substantial earnings miss of -211.43% and a revenue miss of -6.12%. The earnings call highlighted a potential transition of business from a major customer, which represents a material risk to revenue and profitability. This customer loss or transition, combined with operating underperformance relative to expectations, explains the severe market reaction. The company also mentioned it is conducting a strategic alternatives review, suggesting management is exploring options including potential restructuring or asset sales. The combination of earnings disappointment, a significant customer at risk, and the implied distress signal from a strategic review triggered aggressive selling, making FWRD the fifth-largest percentage loser on the day.

AIM

AIM ImmunoTech Inc.Healthcare

$0.34−$0.22

-39.7%

AMEX · Mkt cap $7.3 M

AIM ImmunoTech dropped 39.66% despite announcing positive Phase 2 ovarian cancer trial results and a $4.2M warrant exercise, suggesting investor skepticism about clinical efficacy, dilution concerns, or broader biotech sector weakness unrelated to the headlines.

The news released in the last 48 hours is ostensibly positive: a 50% objective response rate in a Phase 2 ovarian cancer trial combining Ampligen with pembrolizumab and cisplatin, plus a warrant exercise bringing in $4.2 million in gross proceeds. However, the stock fell 39.66%, which is a severe move that contradicts the apparent good news. This discrepancy suggests several non-mutually-exclusive explanations. First, investors may view a 50% ORR as insufficient or may doubt the durability of response in a small Phase 2 cohort. Second, the warrant exercise itself can signal dilution to holders and may indicate the company needed cash urgently. Third, the move could reflect broader biotech sector weakness, clinical trial skepticism, or a delayed market reaction to earlier negative information not captured in this 48-hour window. Without access to the full market context, earnings, or insider trading patterns, it is difficult to pinpoint the exact cause.

CREG

Smart Powerr Corp.Utilities

$0.29−$0.18

-38.3%

NASDAQ · Mkt cap $499 K

No news headlines were found in the last 48 hours, so the 38.30% drop likely reflects either a delayed market reaction to an untracked event, technical selling pressure, or a sector-wide downturn affecting micro-cap energy stocks.

Smart Powerr Corp. is a micro-cap NASDAQ-listed company with a closing price of $0.29, and no recent news was available via Yahoo Finance RSS in the 48 hours preceding this sharp decline. At this market capitalization and price point, stocks are often subject to high volatility and can move sharply on thin volume, rumors, or changes in market sentiment that may not surface as formal news releases. Common catalysts for micro-cap energy or technology stocks include adverse financing announcements, executive departures, contract losses, litigation, or short-seller activity. Without access to press releases, SEC filings, social media chatter, or alternative news sources, we cannot identify a specific trigger. The timing of a 38.30% single-day loss warrants checking for delayed earnings, guidance revisions, or company-specific announcements released outside major news aggregators.

SKIN

The Beauty Health CompanyHealthcare

$0.58−$0.33

-36.3%

NASDAQ · Mkt cap $98 M

SkinHealth Systems reported Q1 earnings late May 7th that missed revenue estimates by 1.85%, triggering a sharp 36% sell-off despite beating earnings per share expectations by 41%.

The company released first-quarter 2026 results on the evening of May 7th. While the earnings surprise was significant at +41.18%, the revenue miss of -1.85% appears to have driven the market's negative reaction. In healthcare and consumer beauty stocks, revenue misses often carry outsized weight because they signal weakening underlying demand or operational headwinds that EPS beats cannot fully offset. The headlines describe this as a "loss" quarter, suggesting the company remained unprofitable despite the EPS beat, which may have disappointed investors betting on a path to consistent profitability. The magnitude of the decline—ranking eighth among all daily losers—indicates this was a material disappointment relative to expectations, particularly for investors who may have anticipated stronger top-line performance heading into the quarter.

BTBD

BT Brands, Inc.Consumer Cyclical

$1.14−$0.62

-35.2%

NASDAQ · Mkt cap $7.5 M

BT Brands terminated its merger agreement with Aero Velocity on May 7, triggering a 35% single-day collapse as investors priced in the loss of the deal's perceived synergies and growth prospects.

The company announced the termination of its previously announced merger with Aero Velocity in a Form 8-K filing on May 7, 2026. The headline indicates management stated a "reaffirmation of commitment to maximizing shareholder value," which is standard boilerplate language when a merger falls apart. However, the market's interpretation is clearly negative: a 35% drop suggests investors had been pricing in meaningful value creation from the merger, and its collapse eliminated that expectation. The stock's ranking as the ninth biggest loser of the day further indicates this was a significant repricing event. Without additional details on deal terms, termination fees, or reasons for the breakup, we cannot determine whether the failure stems from regulatory obstacles, financing collapse, or mutual agreement. The magnitude of the decline suggests shareholders had assigned substantial probability-weighted value to the transaction completing.

SELX

Semilux International Ltd. Ordinary SharesTechnology

$0.24−$0.13

-34.2%

NASDAQ · Mkt cap $1.0 M

No news headlines were found in the last 48 hours to explain the 34.25% decline in SELX, so the cause remains unclear and could stem from technical selling, delayed announcements, or market rumors.

Despite SELX ranking as the tenth biggest loser on the date with a severe single-day drop, no recent news articles were available through Yahoo Finance RSS to identify a specific catalyst. This absence of coverage is itself notable and suggests either that the move occurred without a major announced event, or that the triggering news had not yet been widely disseminated by major outlets. Penny stocks and microcap securities like SELX are particularly susceptible to sharp moves driven by technical factors, short covering reversals, or unverified rumors that may circulate on social media or message boards rather than through formal news channels. Additionally, for illiquid microcap stocks, even modest trading volume can produce outsized percentage moves. Without access to company filings, social media discussion, or broker research, the specific cause cannot be determined from the evidence provided.

GWH

ESS Tech, Inc.Industrials

$0.78−$0.34

-30.3%

NYSE · Mkt cap $23 M

ESS Tech reported Q1 2026 earnings and revenue that missed analyst expectations by 86% and 68% respectively, triggering a 30% stock decline on May 7-8.

ESS Tech disclosed first quarter 2026 financial results on May 7 showing significant underperformance versus consensus estimates. The earnings surprise of negative 86.21% and revenue miss of negative 68.00% represent substantial disappointments that would typically provoke sharp sell-offs in growth or early-stage technology stocks. The magnitude of these misses suggests either a severe operational shortfall, a material change in business trajectory, or a substantial reset of investor expectations about the company's near-term path to profitability. The stock's ranking as the 11th biggest loser on the day reflects broad-based investor repricing following this disclosure. Without access to the full earnings report, specific guidance revisions, or management commentary, we cannot determine whether the miss stemmed from demand weakness, execution issues, cost overruns, or other operational factors, but the scale of the divergence from expectations clearly justified the market's severe reaction.

AORT

Artivion, Inc.Healthcare

$25.41−$10.01

-28.3%

NYSE · Mkt cap $1.3 B

Artivion beat Q1 earnings and revenue estimates and announced a major acquisition of Endospan, but the stock fell 28% anyway, suggesting the market viewed guidance or acquisition terms negatively despite the earnings beat.

The headline evidence presents a paradox. On May 7, Artivion announced Q1 2026 results that beat analyst expectations on earnings (up 33.33%) and slightly beat on revenue (up 0.33%). The company also announced it is exercising an option to acquire Endospan, a vascular device company. Normally either of these events would be stock-positive. However, the 28% single-day drop on May 8 indicates the market reacted very negatively. The most likely explanations, based on typical market behavior, are that either (a) management's full-year 2026 revenue guidance of $488 million fell materially short of consensus expectations, (b) the Endospan acquisition was viewed as dilutive, overpriced, or strategically questionable, or (c) management commentary on the earnings call flagged operational headwinds not visible in the Q1 results themselves. The headlines do not provide the actual guidance figures or acquisition terms, so the specific reason remains unclear.

AKAN

Akanda Corp.Healthcare

$27.00−$10.19

-27.4%

NASDAQ · Mkt cap $2.6 M

No news headlines were available in the last 48 hours to explain the 27.4% drop, so the cause remains unknown without additional reporting or company disclosures.

Akanda Corp. experienced a significant single-day decline of 27.4%, placing it among the top losers on NASDAQ, yet no news articles appeared in the Yahoo Finance RSS feed within the 48-hour window. This absence of public reporting is notable given the magnitude of the move. For a cannabis-related or specialty pharma company like Akan, typical catalysts that drive sharp declines include earnings misses, guidance reductions, regulatory setbacks, licensing issues, or capital market events. Without headline evidence, the drop could reflect an after-hours earnings announcement not yet covered, a private disclosure to institutional investors, technical selling, options-related mechanics, or delayed market reaction to older news. The lack of corroborating headlines makes causal inference difficult.

ZCMD

Zhongchao Inc.Healthcare

$1.58−$0.55

-25.8%

NASDAQ · Mkt cap $6.2 M

No news headlines were available in the last 48 hours to explain ZCMD's steep 25.82% decline, making the underlying catalyst unclear without additional information.

The absence of any recent news coverage leaves the cause of this sharp drop undetermined from publicly available headline sources. For a micro-cap stock like ZCMD trading near $1.58, the most common catalysts for such moves typically include unexpected earnings misses or guidance reductions, sector-wide selloffs affecting Chinese equities, insider selling or dilution announcements, loss of a major contract, regulatory developments, or shifts in short-seller sentiment. Without concrete news, it is also possible the decline reflects delayed market reaction to earlier developments, technical breakdown from key support levels, or liquidity-driven volatility typical of lower-priced stocks. A comprehensive search of SEC filings, company press releases, or industry news would be needed to pinpoint the actual trigger.

SRTS

Sensus Healthcare, Inc.Healthcare

$3.08−$1.03

-25.1%

NASDAQ · Mkt cap $49 M

Sensus Healthcare dropped 25% likely due to disappointing Q1 2026 financial results announced on May 7, though an amicable resolution of a dispute with SkinCure Oncology was also announced on May 8. The earnings miss appears to be the primary driver of the selloff.

Sensus released Q1 2026 financial results on May 7, which triggered the sharp decline. While the company simultaneously announced an amicable resolution of a commercial dispute with SkinCure Oncology on May 8, this positive development was clearly insufficient to offset negative sentiment from the earnings report. The headlines provided do not detail specific financial metrics, revenue misses, guidance cuts, or other quantitative reasons for the decline, so the exact nature of the earnings disappointment remains unclear from available evidence. For a small-cap medical device company, weak quarterly results, reduced revenue guidance, margin compression, or cash burn concerns would typically drive this magnitude of selloff. The dispute resolution, while positive, appears to have been overshadowed by the earnings narrative.

Skycorp Solar Group LimitedEnergy

$5.81−$1.90

-24.6%

NASDAQ · Mkt cap $5.4 M

Skycorp Solar announced an Extraordinary General Meeting, which typically signals potential material corporate actions such as restructuring, governance changes, or strategic decisions that spooked investors, driving a 24.64% sell-off in the solar connector/cable manufacturer.

The only concrete news from the past 48 hours is the announcement of an Extraordinary General Meeting (EGM) scheduled by Skycorp Solar. While the provided headline does not specify the agenda or purpose of the EGM, such announcements often precede significant corporate events including shareholder votes on major transactions, capital restructures, changes in board composition, or strategic pivots. For a small-cap solar products company trading at $5.81, an unexpected EGM can trigger uncertainty and risk-off selling, particularly if institutional holders interpret it as a sign of financial distress, dilutive financing, or loss of operational control. The scale of the single-day decline (rank 16 biggest loser) suggests a genuine material catalyst rather than sector-wide weakness, though without disclosure of the EGM's actual agenda, we cannot definitively rule out competing explanations such as short-seller activity, margin calls in the underlying solar industry, or delayed disclosure of prior negative news.

FCHL

Fitness Champs Holdings Limited Common StockConsumer Defensive

$1.73−$0.56

-24.5%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 24.45% drop on FCHL likely stems from a delayed announcement, technical selling, or market-specific event not yet reflected in major financial news feeds.

The absence of any headlines in the 48-hour window preceding this steep decline makes direct attribution impossible. For a microcap fitness-related company trading at $1.73, potential catalysts could include disappointing earnings or guidance released after market close, an insider sale or dilutive capital event, broader sector weakness in health and fitness stocks, or accumulated technical selling pressure. Retail-heavy or thinly traded securities in this price range are also susceptible to momentum reversals and gap fills without company-specific news. Without corroborating information, the decline remains unexplained by the available evidence.

KMLI

KraneShares 2x Long MELI Daily ETF

$8.09−$2.61

-24.4%

NASDAQ

No news headlines appeared in the last 48 hours, but KMLI is a 2x leveraged long ETF on MELI (Mercado Libre), so a roughly 12% drop in the underlying stock would mechanically produce approximately this 24% loss through leverage amplification.

No recent news was found in the provided headlines, so the direct cause of today's move cannot be attributed to any announced event. However, KMLI's structure as a 2x daily leveraged ETF means it is designed to amplify daily movements of its underlying asset, Mercado Libre (MELI). A significant drop in MELI stock would be mechanically reflected as roughly double that percentage loss in KMLI. The 24.37% decline in KMLI is consistent with a roughly 12% fall in MELI itself. Without news on KMLI or MELI appearing in the last 48 hours, the underlying catalyst for MELI's decline is not evident from the provided sources, but typical catalysts for large single-day drops in individual equities include earnings misses, analyst downgrades, sector selloffs, macro concerns, or company-specific operational news.

FIGS

FIGS, Inc.Consumer Cyclical

$11.63−$3.74

-24.3%

NYSE · Mkt cap $2.4 B

FIGS reported strong Q1 earnings with 28% revenue growth and a 125% earnings beat, but the stock collapsed 24% anyway, suggesting the market is pricing in unsustainable valuation despite impressive fundamentals.

The headlines establish that FIGS delivered objectively strong results on May 7-8: revenue beat expectations with 28% year-over-year growth to $159.9 million, and earnings surprised 125% to the upside at $0.03 per share versus $0.02 expected. The company explicitly stated it is "off to an incredible start to the year." One headline directly addresses the disconnect, titled "Why Figs Stock Crashed Today" with the subheading "Figs earnings weren't nearly as bad as you think -- but its stock is still very expensive." This points to a valuation reset: the market may have priced in even stronger growth expectations or lower multiples, or investors are rotating away from expensive growth stocks. The 15% initial drop on earnings night followed by an additional 9% drop the next day suggests selling pressure beyond the initial reaction, possibly driven by broader market conditions or analyst downgrades not captured in the headlines provided.

TSSI

TSS, Inc.Technology

$12.02−$3.82

-24.1%

NASDAQ · Mkt cap $266 M

TSS reported strong Q1 2026 results with 88% revenue growth and refined upward full-year EBITDA guidance on May 7, yet the stock fell 24% the next day, suggesting the market either found the guidance disappointing relative to expectations or reacted to undisclosed negative commentary during earni…

The headlines show TSS released Q1 2026 earnings on May 7 with total revenue of $55.3 million and systems integration revenue up 88% year-over-year, while refining full-year 2026 adjusted EBITDA guidance toward the high end of a $20–22 million range. On the surface these appear positive metrics. However, the 24% single-day drop on May 8 indicates the market's reaction was sharply negative. This could reflect several scenarios: the guidance range itself was seen as insufficiently ambitious given the strong organic growth rate, management commentary on margins or demand trends was cautious, or the stock had been priced for more aggressive forward guidance. The May 8 news about presenting at the Needham Conference is a minor corporate event unlikely to trigger a 24% drop on its own. Without access to the full earnings call transcript or detailed forward commentary, the exact reason for the selloff cannot be definitively established from headlines alone.

AREB

American Rebel Holdings, Inc.Consumer Cyclical

$0.17−$0.05

-24.1%

NASDAQ · Mkt cap $4.8 M

American Rebel announced a beer distribution placement at a new Florida venue on May 7, but this positive news coincided with a sharp 24% single-day drop, suggesting the market reaction was driven by factors unrelated to the headline announcement.

The only headline provided is a press release from May 7 announcing American Rebel Light Beer securing placement at Tootsie's PCB, a new beachfront entertainment venue in Panama City Beach. This is typically framed as positive news for a beverage company, yet the stock fell 24% the following day. This sharp decline contradicts any bullish signal from the distribution deal. Possible explanations include negative analyst commentary or earnings disappointment released simultaneously but not captured in the RSS feed provided, a broader sector selloff in small-cap beverages, concerns about the company's financial runway or burn rate, dilution from a capital raise, or a technical capitulation in a stock that may already have been under pressure. Without additional context on company fundamentals, cash position, or competing news, the exact catalyst remains unclear.

NET

Cloudflare, Inc.Technology

$195.81−$60.98

-23.7%

NYSE · Mkt cap $99 B

Cloudflare announced a 20% workforce reduction (1,100 employees) due to AI efficiency gains, causing a sharp 23.75% stock decline despite record revenue and generous severance packages that the market viewed unfavorably.

Cloudflare's announcement on May 8 that it would cut 1,100 jobs (approximately 20% of workforce) as a result of AI-driven efficiency improvements triggered the stock's sharp decline. While the company highlighted record-high revenue and offered severance through year-end that CEO Matthew Prince claimed would "lead the industry," the market interpreted the large-scale layoff negatively. Multiple headlines note that analysts and market observers questioned whether AI-driven cost-cutting announcements like Cloudflare's and Coinbase's would be rewarded by investors. The broader market context shows strong tech gains on AI demand and jobs data, but Cloudflare diverged sharply, suggesting company-specific factors rather than sector weakness drove the sell-off.

CRWG

Leverage Shares 2x Long CRWV Daily ETFFinancial Services

$46.53−$14.17

-23.3%

RMSG

Real Messenger CorporationTechnology

$1.38−$0.41

-22.9%

NASDAQ · Mkt cap $5.4 M

Real Messenger announced compliance with Nasdaq minimum bid price requirements on May 7, but the stock fell 22.91% the next day; the news itself is positive, suggesting the sell-off may reflect profit-taking, market skepticism about sustainability, or an unrelated negative catalyst not captured i…

The only headline provided is the company's announcement on May 7 that it has regained compliance with Nasdaq's minimum bid price requirement, which is ordinarily a positive development that prevents delisting. However, the stock dropped sharply the following trading day, which is counterintuitive. This disconnect suggests either that: (1) investors are skeptical the compliance will hold and view this as a temporary reprieve rather than a fundamental fix, or (2) the sell-off is driven by an unrelated market event, sector rotation, or negative news that did not appear in the Yahoo Finance RSS feed captured here. The company operates in the chat-based real estate platform space, which may be sensitive to broader fintech sentiment or real estate market concerns. Without additional headlines or context about broader market conditions, attributing the decline solely to the compliance announcement strains credibility.

MOBI

Mobia Medical, Inc. Common StockHealthcare

$11.75−$3.25

-21.7%

NASDAQ · Mkt cap $380 M

Mobia Medical's IPO pricing announcement on May 7 likely triggered the 21.67% one-day drop, consistent with typical post-IPO first-day or early trading volatility as the market discovers equilibrium price away from the offering price.

The only news headline provided is Mobia Medical's IPO pricing announcement released May 7 at 02:10 UTC, which aligns temporally with the May 8 trading session price action. The headline is truncated and does not specify the IPO price or any other details, but the timing suggests this is a newly public company on its first or second trading day. IPO stocks frequently experience sharp single-day moves as retail and institutional demand clash with supply, underwriters' stabilization roles unwind, and early investors lock in gains or losses. A 21.67% decline on day one or two of trading is well within the normal range for IPO volatility, particularly for medical device companies which can be speculative. Without the actual IPO pricing details, prospectus, or broader market context for May 8, we cannot rule out secondary factors like sector rotation or company-specific forward guidance, but the IPO announcement timing provides the most grounded explanation.

DXC

DXC Technology CompanyTechnology

$9.43−$2.58

-21.5%

NYSE · Mkt cap $1.9 B

DXC Technology fell 21.48% on disappointing forward guidance despite beating Q4 earnings estimates. The company's guidance for next quarter revenue of $2.99 billion signals a sharp sequential decline from $3.13 billion in Q1, alarming investors about demand weakness ahead.

DXC reported Q4 earnings that beat estimates by 4.76% and demonstrated margin discipline and strong cash flow execution, which would normally support the stock. However, the company simultaneously disclosed that Q1 CY2026 (or fiscal Q1 2027) revenue guidance of $2.99 billion represents a 4.5% sequential decline from the just-reported quarter, signaling softer customer demand. This forward-looking weakness appears to have overshadowed the earnings beat. For an IT services provider already facing year-over-year revenue declines of 1.2%, a sequential guidance miss suggests accelerating headwinds in the business, which likely triggered the sharp sell-off as investors repriced the trajectory of future cash flows and profitability.

Outset Medical, Inc.Healthcare

$3.70−$0.99

-21.0%

NASDAQ · Mkt cap $79 M

Outset Medical fell 21% after reporting Q1 earnings that missed both EPS and revenue estimates, despite management commentary on operational progress, signaling investor disappointment with financial performance relative to expectations.

On May 7, Outset Medical released Q1 2026 results showing revenue of $27.9 million with negative earnings surprises of 5.06% on EPS and 3.59% on revenue. While management highlighted positive operational metrics—console utilization, new customer additions, gross margin expansion, and cash discipline—the actual financial results fell short of consensus estimates. The headlines note variability in capital order timing impacted results. For a small-cap medical device company with limited profitability, missing estimates on both the top and bottom lines typically triggers sharp selloffs regardless of qualitative operational commentary, as investors reprrice near-term earnings power and cash burn. The 21% single-day decline suggests the magnitude of the miss or guidance implications disappointed the market enough to warrant a significant repricing.

AMPH

Amphastar Pharmaceuticals, Inc.Healthcare

$19.00−$5.03

-20.9%

NASDAQ · Mkt cap $1.0 B

Amphastar reported Q1 2026 earnings that missed analyst expectations significantly, with non-GAAP EPS down 40.5% versus estimates and revenue essentially flat year-over-year, triggering the sharp 20.9% stock decline.

The headlines establish that Amphastar released Q1 2026 results on May 7–8, 2026 showing net revenues of $171.2 million, up only 0.27% versus the prior year quarter despite recently launched products. More critically, the company's non-GAAP earnings per share of $0.42 fell 40.5% below Wall Street estimates. The earnings surprise was substantial at negative 40.28%, which typically drives sharp repricing in pharma stocks. While the headlines note that newly launched products helped offset pricing pressure, the magnitude of the EPS miss relative to expectations appears to have overwhelmed any positive narrative around product launches or revenue stability. The market's reaction reflects disappointment in profitability trends despite flat revenue, suggesting margin compression or cost pressures that investors did not fully anticipate.

FLUX

Flux Power Holdings, Inc.Industrials

$1.03−$0.27

-20.8%

NASDAQ · Mkt cap $16 M

Flux Power reported a Q3 2026 loss and missed revenue estimates by 35.60%, triggering the 20.77% single-day decline on earnings release day.

Flux Power released Q3 2026 financial results on May 7, 2026, reporting a significant loss and a revenue miss of 35.60% versus expectations. The earnings surprise metric of -366.67% indicates the loss was substantially worse than consensus forecasts, suggesting investor expectations were not aligned with actual operational performance. The stock's 20.77% decline on May 8 directly follows the earnings announcement and call, making this a classic post-earnings selloff driven by negative surprise. The company develops lithium-ion energy storage solutions and electrification software, a sector sensitive to execution, margins, and growth rates. Investors appear to have repriced the stock based on deteriorating financial performance relative to guidance or analyst consensus.

KDK

Kodiak AI, Inc. Common StockTechnology

$7.25−$1.86

-20.4%

NASDAQ · Mkt cap $738 M

Kodiak AI fell 20% despite announcing strong operational progress, a $100M financing round, and new commercial partnerships on May 7–8, suggesting the market reacted negatively to dilution from the PIPE offering or unmet growth expectations relative to valuation.

The headlines establish that Kodiak announced Q1 2026 results, a $100 million PIPE financing, deployment of driverless trucks (28 total), over 23,500 cumulative operating hours, and three significant new partnerships including Roehl Transport, General Dynamics, and West Fraser. These are operationally positive developments. However, a 20% single-day drop on news that includes a large equity raise suggests investor disappointment with either the financing terms (shareholder dilution), the pace of revenue growth relative to cash burn, or forward guidance. The timing—earnings call on May 8 morning followed by sharp decline—points to a narrative miss: shareholders may have expected stronger commercial traction, higher revenue guidance, or better unit economics than what management disclosed. Without access to the full earnings transcript, the precise disappointment cannot be pinpointed, but the magnitude of the drop is inconsistent with "operationally on track" sentiment.

Nano Labs LtdTechnology

$1.65−$0.42

-20.3%

NASDAQ · Mkt cap $45 M

No news headlines were found in the last 48 hours for Nano Labs Ltd, so the 20% decline cannot be directly attributed to a specific company announcement or event. The drop may reflect sector weakness, technical selling, or delayed market reaction to an earlier event not captured in the search win…

The absence of any news in the provided headlines makes it impossible to pinpoint a specific catalyst for the 20.29% price decline. Nano Labs is a small-cap stock trading at $1.65, which typically means it is more volatile and sensitive to both company-specific events and broader market movements. Possible explanations for this magnitude of drop include broad semiconductor or technology sector weakness if Nano Labs operates in that space, technical selling pressure triggered by a breakdown through key support levels, a delayed market reaction to news that broke before the 48-hour window, or less commonly for stocks at this price point, insider selling or short-seller activity. Without access to the company's recent earnings reports, SEC filings, or sector news, determining the true cause requires additional information.

HRTG

Heritage Insurance Holdings, Inc.Financial Services

$22.41−$5.62

-20.1%

NYSE · Mkt cap $1.0 B

Heritage Insurance Holdings missed Q1 earnings expectations by 22.22% and revenue by 1.50%, triggering a sharp 20% stock decline as the market repriced the underperforming insurer on weaker-than-expected profitability.

Heritage Insurance reported first quarter 2026 results on May 7 that fell materially short of analyst estimates. The company delivered an earnings surprise of negative 22.22 percent, meaning earnings came in roughly one-quarter below expectations, alongside a smaller revenue miss of 1.50 percent. For an insurance holding company where underwriting profitability and loss ratios are core to valuation, an earnings miss of this magnitude signals either deteriorating underwriting conditions, higher-than-expected claims, or operational headwinds. The same-day earnings call summary was published but provides no additional detail in the available headlines. The contrast with peer HCI Group, which beat earnings estimates that same quarter, underscores that sector headwinds alone do not explain the magnitude of HRTG's miss, pointing instead to company-specific underperformance.

AHMA

Ambitions Enterprise Management Co. L.L.CConsumer Cyclical

$1.41−$0.35

-19.9%

NASDAQ · Mkt cap $46 M

No news headlines were published in the last 48 hours about AHMA, so the 19.89% decline cannot be attributed to a specific disclosed event; the drop likely reflects technical selling, market conditions, or undisclosed company developments.

The absence of any news headlines in the last 48 hours means we cannot point to an earnings miss, guidance cut, regulatory action, or other headline-driven catalyst for this sharp 20% loss. For a micro-cap or thinly traded stock like AHMA trading at $1.41, declines of this magnitude are most commonly caused by one of several factors: technical selling following a failed breakout or support level, broad market volatility affecting low-liquidity equities disproportionately, an undisclosed announcement or rumor not yet reflected in major news feeds, insider selling, or deterioration in sentiment about the business that precedes formal news. Without access to company filings, regulatory announcements, or social media activity, we cannot distinguish between these possibilities. The lack of coverage also suggests this may be a smaller or less-followed company where news dissemination lags or where moves are driven more by retail trading or technical factors than fundamental catalysts.

HTOO

Fusion Fuel Green PLCUtilities

$2.73−$0.67

-19.7%

NASDAQ · Mkt cap $16 M

Fusion Fuel reported €14.4 million in fiscal 2025 revenue and provided a business update on May 7, but the 19.7% stock decline suggests the market may have viewed the results or guidance as disappointing relative to expectations.

The company released earnings and a business update after market close on May 7, and the stock fell sharply the next trading day. The headline snippet cuts off before providing financial metrics, margins, profitability, guidance, or forward-looking commentary that would indicate whether results beat or missed analyst expectations. For a small-cap green hydrogen and energy engineering firm, investor focus typically centers on: revenue growth rate relative to prior year, path to profitability, contracted backlog visibility, capital deployment updates, and management guidance on expansion plans. The modest €14.4 million in annual revenue for a public company suggests HTOO is early-stage, which makes execution risk and forward outlook paramount. Without seeing the full earnings release details, margins, or any cautionary commentary, the sharp decline most likely reflects either downward guidance, lower-than-expected margins, delayed project timelines, or a shortfall in new contract announcements relative to investor hopes for this sector.

RIME

Algorhythm Holdings, Inc.Technology

$0.61−$0.15

-19.4%

NASDAQ · Mkt cap $4.9 M

No news headlines were found in the last 48 hours to explain RIME's 19.38% drop, so the decline likely stems from technical selling, a delayed announcement, or sector-wide pressure not captured in the provided sources.

The absence of any recent news headlines for Algorhythm Holdings makes it difficult to pinpoint a specific catalyst for today's sharp 19.38% decline. Given that RIME trades on NASDAQ at a low price point ($0.61) and ranked as the 35th biggest loser, the move is material. Possible drivers include technical deterioration or a widening bid-ask spread typical of lower-priced stocks, profit-taking after a prior run-up, sector-wide headwinds not reflected in the news feed provided, or a company announcement released outside the 48-hour window or not yet indexed by Yahoo Finance. Without access to press releases, SEC filings, or social media discussion, the specific cause remains opaque. Stocks in this price range often experience volatile moves on relatively low volume and limited news visibility.

KODK

Eastman Kodak CompanyIndustrials

$11.41−$2.74

-19.4%

NYSE · Mkt cap $896 M

Kodak fell 19.36% on May 8 following the release of its Q1 2026 earnings results on May 7, suggesting the financial results, guidance, or commentary disappointed investors enough to trigger a sharp sell-off.

Kodak released its Q1 2026 earnings results on May 7, 2026, with the Form 10-Q filing and earnings call occurring on May 8. The timing of the stock's 19.36% drop coinciding precisely with earnings announcement strongly implicates the financial results themselves as the trigger. However, the headlines provided do not include the actual earnings figures, revenue, profitability metrics, or forward guidance that would explain why the market reacted so negatively. A 19.36% single-day loss typically reflects either a significant earnings miss relative to consensus expectations, a sharp downward revision to guidance, or disappointing commentary on business trends. Without access to the actual numbers or specific management commentary excerpts, we cannot pinpoint whether the issue was revenue shortfall, margin compression, cash burn, competitive headwinds, or other operational concerns. The magnitude of the decline suggests material disappointment rather than a minor miss.

CHSN

Chanson International HoldingConsumer Cyclical

$1.48−$0.35

-19.1%

NASDAQ · Mkt cap $2.6 M

CHSN fell 19.13% on May 8 despite a positive May 7 press release about AI-driven manufacturing strategy, suggesting the market either viewed the announcement as insufficient or a separate negative catalyst drove the decline.

The only headline provided is a growth strategy announcement from May 7 emphasizing AI and intelligent manufacturing upgrades. This is typically viewed as constructive news, yet the stock dropped sharply the following day, ranking as the 37th biggest loser. This disconnect suggests either that investors found the announcement disappointing or underwhelming relative to expectations, or that an entirely different negative catalyst emerged that was not captured in the available headlines. Possible causes include broader market sell-off pressure on small-cap China-exposed stocks, a missed earnings or guidance revision not yet reflected in the RSS feed, insider selling, or trading in anticipation of earnings. Without additional negative news in the headlines, the decline appears disconnected from the published narrative, making the true driver unclear.

HUBS

HubSpot, Inc.Technology

$197.34−$46.38

-19.0%

NYSE · Mkt cap $12 B

HubSpot plunged 19% after beating Q1 earnings and raising guidance, but the market reacted negatively to simultaneous pricing changes, an agent-first go-to-market shift, and AI monetization uncertainty that analysts view as significant execution risk.

HubSpot reported a beat-and-raise quarter with strong multi-hub customer growth and AI-driven revenue acceleration, yet the stock tanked. The disconnect reflects analyst concern about execution risk from concurrent strategic changes. Bank of America downgraded the stock, citing simultaneous shifts to new pricing models and an agent-first sales approach as posing "significant" execution challenges. Multiple headlines frame this as AI-driven uncertainty threatening the SaaS business model's traditional licensing structure. Morgan Stanley acknowledged growth stability but flagged near-term AI pricing and packaging challenges. The market appears to have punished execution risk and strategic transition uncertainty despite near-term financial beats, suggesting investors fear near-term disruption outweighs positive metrics.

PAL

Proficient Auto Logistics, Inc. Common StockIndustrials

$5.95−$1.39

-18.9%

NASDAQ · Mkt cap $158 M

Proficient Auto Logistics reported a Q1 loss and cited weather disruptions, automotive plant shutdowns, weak industry volumes, and elevated diesel costs as headwinds, triggering an 18.94% sell-off despite beating revenue estimates.

The company announced Q1 2026 results on May 7 with a reported loss (earnings surprise of -800%) while revenue beat expectations by 2.51%. The earnings call highlights reveal multiple operational pressures: weather disruptions, extended automotive plant shutdowns reducing freight demand, weak overall industry volumes, and a late-quarter spike in diesel costs that compressed margins. Despite the revenue beat, the unexpected loss and management commentary on industry headwinds appear to have overshadowed the topline strength. For a logistics company dependent on automotive shipments and diesel fuel costs, the confluence of demand weakness and fuel cost inflation is a material concern for profitability going forward. The market has repriced the stock sharply downward, suggesting investors interpret these conditions as more persistent than transitory.

CAI

Caris Life Sciences, Inc.Healthcare

$16.15−$3.69

-18.6%

NASDAQ · Mkt cap $7.2 B

Caris Life Sciences dropped 18.6% despite positive Q1 earnings and revenue growth on May 7, likely due to disappointing guidance, margin concerns, or unmet investor expectations revealed during the earnings call.

The company released Q1 2026 results on May 7 showing year-over-year revenue growth, improving margins, and pipeline progress including a clinical accuracy result. The earnings call highlights mention positive developments, and a separate news item notes a New York State Department of Health application submission for blood-based testing authorization. However, the magnitude of the sell-off suggests investors reacted negatively to specific commentary during the earnings call or forward guidance that contradicted the headline positives. Biotech and precision medicine companies with clinical-stage assets are sensitive to guidance revisions, margin trajectories, cash burn rates, and pipeline probability assessments. The timing of the decline directly after earnings suggests the call content, not the positive news itself, drove the move. Without access to full call transcript details or specific guidance metrics, the exact disappointment cannot be pinpointed.

ANTA

Antalpha Platform Holding CompanyFinancial Services

$7.93−$1.81

-18.6%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours to explain ANTA's 18.58% decline, so the trigger remains unclear; the drop may reflect broader market sentiment, a delayed disclosure, or sector-specific headwinds.

Despite ANTA's sharp decline to rank among the day's 41 biggest losers, no relevant news articles appeared in the Yahoo Finance RSS feed over the past two days. This absence of reported news does not rule out an actual catalyst—earnings could have been released, guidance lowered, or a corporate action announced through other channels—but we cannot confirm any such event from the evidence provided. Without visibility into ANTA's sector classification, recent earnings calendar, or analyst sentiment, reasonable hypotheses for the move include a delayed earnings disappointment, sector rotation away from tech or similar groups, or a company-specific corporate action not yet reflected in major news feeds. The lack of headline coverage itself is noteworthy and limits confidence in identifying the true driver.

LKSPR

Lake Superior Acquisition Corp. – Rights

$0.92−$0.21

-18.2%

NASDAQ

No news emerged in the last 48 hours, so the 18% drop in LKSPR rights likely reflects either broad market weakness, expiration dynamics of the rights offering, or deteriorating sentiment toward the underlying SPAC deal.

Lake Superior Acquisition Corp. rights are derivative securities tied to a blank-check company's merger prospects. With no recent news available, the move cannot be attributed to a specific catalyst. Rights offerings are sensitive to several structural factors: expiration date approaches (rights lose value as exercise deadlines near), changes in the value or probability of the underlying SPAC merger, redemption announcements by the sponsor or shareholders, or shifts in market risk appetite for speculative equity vehicles. SPAC-related instruments have faced structural headwinds since 2021, and rights specifically are leveraged bets that amplify losses when confidence wanes. The 18% single-day drop for a rights instrument suggests either a technical sell-off in a thinly traded security or a material event in the SPAC story itself that simply did not appear in the 48-hour news window captured.

CDLX

Cardlytics, Inc.Communication Services

$0.64−$0.14

-18.1%

NASDAQ · Mkt cap $24 M

Cardlytics reported Q1 2026 earnings on May 7-8, and the 18% drop suggests the market reacted negatively to either financial results, forward guidance, or operational commentary, though the headlines do not disclose specific metrics or management warnings.

The timing is clear: Cardlytics released first-quarter 2026 financial results and held an earnings call on May 7-8, coinciding directly with the stock's sharp 18% decline. The provided headlines confirm earnings were announced and a call occurred, but they offer only generic language about "strong operational performance" and "expanding reach." The headlines do not reveal actual revenue, earnings-per-share, profit margins, guidance changes, or any specific operational concerns management flagged. For a commerce media platform, typical sell-off triggers would include guidance cuts, slower advertiser spending trends, churn among bank partners, or margin compression. Without access to the actual financial figures or detailed commentary from the call transcript excerpts, we cannot pinpoint which specific metric disappointed the market, only that something in the results or outlook prompted institutional selling.

MTVA

MetaVia Inc.Healthcare

$1.09−$0.24

-18.0%

NASDAQ · Mkt cap $7.6 M

No news headlines were found in the last 48 hours for MTVA, so the 18% drop likely reflects a delayed market reaction to an earlier announcement, technical selling pressure, or an untracked catalyst such as insider activity or sector headwinds.

The absence of any Yahoo Finance headlines in the most recent 48-hour window makes it impossible to pinpoint a specific near-term catalyst for MetaVia's sharp 18% decline. For a micro-cap stock trading below $1.10, declines of this magnitude can occur for several reasons: a delayed market digestion of older news not captured in the RSS feed, deterioration in sentiment toward a broader category the company occupies (such as digital media, blockchain, or AI applications), changes in analyst coverage or downgrades, insider selling, or purely technical breakdown in a stock with typically low volume and liquidity. Without access to the company's recent investor relations activity, earnings calendar, or patent and regulatory filings from the prior week, attribution remains speculative. The rank as the 44th biggest loser suggests meaningful participation rather than isolated trading noise, pointing toward something systemic rather than purely random.

LCUT

Lifetime Brands, Inc.Consumer Cyclical

$5.91−$1.28

-17.8%

NASDAQ · Mkt cap $228 M

Lifetime Brands reported Q1 earnings that beat estimates by over 100% on earnings and 3.8% on revenue, yet the stock fell 17.8%, suggesting investors either expected even stronger results, had concerns about forward guidance, or reacted to underlying margin or cash flow issues not fully captured …

The headlines establish that LCUT delivered a significant earnings surprise (122.86% beat) and modest revenue beat (3.80%) on May 7, with management citing momentum from late 2025, pricing actions, and cost discipline. The earnings call transcripts and summaries were published, yet the stock dropped sharply the next day. This pattern typically reflects a sell-the-news dynamic where the market had priced in the beat ahead of the release, or where investors who reviewed the full earnings call details found concerns about forward guidance, margin sustainability, working capital, or competitive pressures that the headline beats obscured. Without access to the actual guidance statements or margin trends discussed, the precise trigger remains unclear, but the divergence between strong beats and sharp decline suggests the market viewed something in the details as disappointing relative to expectations.

OSRH

OSR Holdings, Inc.Healthcare

$0.57−$0.12

-17.5%

NASDAQ · Mkt cap $21 M

No news was published in the last 48 hours, so the 17.45% decline cannot be attributed to a specific announced event. The drop likely reflects either delayed market reaction to prior news, technical selling, or micro-cap volatility common in sub-dollar stocks.

The absence of recent headlines makes it impossible to pinpoint a discrete catalyst for OSRH's sharp decline. Stocks trading below one dollar, particularly those with limited liquidity and research coverage, are prone to outsized daily swings driven by technical factors, thin order books, or delayed reactions to information released more than 48 hours ago. Another possibility is that negative news broke outside the Yahoo Finance RSS feed captured here, or that the move reflects broader sector pressure or short-term trading activity rather than fundamental news. Without access to company filings, insider trading patterns, or social media discussion, any specific cause remains speculative.

REAL

The RealReal, Inc.Consumer Cyclical

$10.26−$2.14

-17.3%

NASDAQ · Mkt cap $1.2 B

The RealReal reported strong Q1 revenue growth and beat estimates on May 7th, but a major shareholder (Penn Capital) unloaded 1.13 million shares following the stock's recent run, likely triggering a sell-off that erased investor enthusiasm despite solid fundamentals.

The RealReal announced Q1 2026 results on May 7th showing its fourth consecutive quarter of double-digit top-line growth and third consecutive quarter exceeding 20% growth, with a revenue beat of 1.10% versus estimates and improved operating cash flow. These are objectively positive metrics. However, on the same day Penn Capital announced it was selling 1.13 million shares following what the headline characterizes as a massive stock run-up. This large insider or major shareholder liquidation arriving immediately after earnings announcement likely created a negative sentiment reversal, signaling that existing holders were taking profits despite the strong operational performance. The 17.26% single-day drop suggests investors interpreted the selling pressure as a vote of no confidence in current valuation levels, overwhelming the positive earnings surprise.

ZEPP

Zepp Health CorporationTechnology

$12.37−$2.58

-17.3%

NYSE · Mkt cap $81 M

No news headlines were found in the last 48 hours, so the 17.26% drop cannot be attributed to a specific announced event; the cause likely falls into broad categories such as sector weakness, technical selling, or undisclosed company developments.

Zepp Health Corporation suffered a sharp 17.26% decline with zero news headlines in the prior 48 hours to explain the move. This absence of reported catalysts suggests the sell-off was either triggered by factors not yet captured in major news feeds, driven by technical or market-wide pressures, or based on rumors or commentary that have not yet materialized into formal announcements. Zepp is a consumer health and wearables company, making it susceptible to several typical drivers: weakness in the broader consumer discretionary or tech sectors, concerns about China-specific regulatory or market risks, competitive pressure in the wearables space, or delayed earnings-related sentiment shifts. Without headline evidence, the specific trigger remains unclear and could be anything from a sector rotation to a pending announcement not yet widely reported.

HCAI

Hauchen AI Parking Management Technology Holding Co., Ltd.Industrials

$12.00−$2.50

-17.2%

NASDAQ · Mkt cap $7.9 M

No news headlines were found in the last 48 hours, so the 17.24% decline cannot be directly attributed to a disclosed event. The drop likely reflects broader market sentiment, technical selling, or undisclosed company-specific developments.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for HCAI's sharp 17% decline on May 8, 2026. For a smaller-cap NASDAQ stock focused on AI parking management technology, typical drivers of single-day losses of this magnitude include earnings misses or guidance cuts, unexpected operational setbacks, executive departures, competitive pressures, or shifts in investor sentiment regarding the AI or parking-tech sectors more broadly. Alternatively, the move could reflect technical factors such as stop-loss cascades, options-related hedging, or a delayed market reaction to news released outside the 48-hour window captured here. Without access to intraday news, SEC filings, or social media commentary from that specific date, attributing causality is speculative.

SOUX

Daily Target 2X Long SOUN ETF

$24.37−$5.03

-17.1%

NASDAQ

No news headlines were published in the last 48 hours, but the 17% drop in this 2X leveraged ETF likely reflects a significant decline in its underlying security SOUN, amplified by the leverage factor.

The absence of any news headlines in the 48-hour window means no specific corporate announcement, earnings release, regulatory action, or guidance change can be identified as the direct cause of the move. However, SOUX is a daily target 2X long leveraged ETF tracking SOUN, which means its price movements are mechanically amplified versions of the underlying stock. A roughly 8-9% decline in SOUN would produce approximately a 17% decline in SOUX under normal conditions. This suggests the underlying equity SOUN experienced a significant one-day selloff. Without headline evidence, the catalyst could be a delayed news release not yet reflected in the RSS feed, broad market weakness in the audio or consumer electronics sector, technical selling, or pre-existing negative sentiment toward SOUN that crystallized on this particular trading day.